Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DB25FP3KR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,414
Award facts
- Contract value 100% obligated
- $16,414.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,414.32 to AmerisourceBergen Drug Corp for the supply of Kesimpta 20 mg/0.4 ml pen injections. This firm fixed-price delivery order, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-competitive, non-set-aside award to the prime contractor's Corporate Office division located in Conshohocken, Pennsylvania. Kesimpta is a disease-modifying therapy used in the treatment of multiple sclerosis, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceutical products to support military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products, brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs globally. AmerisourceBergen's sustained contract activity with the Defense Logistics Agency demonstrates its established capability as a critical vendor for federal medical procurement and its role in supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FP3KR?
SPE2DB25FP3KR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FP3KR worth?
The government has obligated $16,414 on SPE2DB25FP3KR.
Is contract SPE2DB25FP3KR an order under another contract?
Yes. SPE2DB25FP3KR is a delivery order under SPE2DB22D3010, an indefinite delivery contract.
Was contract SPE2DB25FP3KR competed?
The extent of competition for SPE2DB25FP3KR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award